Study to Investigate the Safety, Pharmacokinetics, Pharmacodynamics, and Clinical Activity of GSK2126458 and GSK1120212 Combination Therapy in Subjects With Advanced Solid Tumors.

This study has been terminated.

(The reason for termination was lack of tolerability and efficacy of the combination treatment)

Sponsor:

Information provided by (Responsible Party):

GlaxoSmithKline

ClinicalTrials.gov Identifier:

NCT01248858

First received: November 18, 2010

Last updated: April 28, 2016

Last verified: April 2016

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been terminated.
Study Completion Date:	April 2015
Primary Completion Date:	January 2014 (Final data collection date for primary outcome measure)